Reimbursement, Not Off-Label Use, May Be Hindering Carotid Stent Trials

Enrollment of randomized trials of carotid stents in low-risk patients has been slow because many doctors have an economic incentive to prevent their patients from being randomized, according to Kenneth Rosenfield, M.D., Massachusetts General Hospital